The limitations of clinical endpoints further compound the problem
The utilisation of omics approaches such as scRNAseq to delineate the specific effects of ROS modulation in individual cell types during different stages of wound healing and chronic wound pathogenesis would additionally be of benefit for this purpose
Clinical experience suggests good tolerability, with: Mild injection site reactions Occasional digestive changes (particularly with oral administration) Rarely reported headache Important Safety Considerations Both peptides should be prescribed and monitored by qualified medical providers Quality of peptide sourcing matters compounding pharmacies should be licensed and regulated Lab monitoring (particularly IGF-1 for sermorelin) is essential for ongoing safety Contraindications (active malignancies, certain medical conditions) must be evaluated Medical Disclaimer Sermorelin was previously FDA-approved for diagnostic use (Geref Diagnostic) and is currently prescribed off-label through compounding pharmacies
The Precision Peptide Genetic Test does not predict response to any specific compound
By reducing oxidative stress, glutathione slows skin aging, marked by wrinkles, fine lines, and loss of elasticity
7.4.1.3 Vascular endothelial growth factor (VEGF) VEGF is a critical regulator of angiogenesis and vascular permeability